SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $12,000 | +9.1% | 2,156 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $11,000 | -21.4% | 2,156 | +22.6% | 0.00% | 0.0% |
Q1 2022 | $14,000 | -46.2% | 1,759 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $26,000 | -21.2% | 1,759 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $33,000 | +3.1% | 1,759 | +1.4% | 0.00% | 0.0% |
Q2 2021 | $32,000 | -22.0% | 1,734 | -4.7% | 0.00% | -33.3% |
Q1 2021 | $41,000 | +78.3% | 1,820 | +65.9% | 0.01% | +50.0% |
Q4 2020 | $23,000 | – | 1,097 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
BVF INC/IL | 826,825 | $15,619,000 | 0.61% |